List of Sessions - 바카라 사리트 CME 165

Speaker: Mary Tinetti, MD

• What does the "5 Ms" mean?
• How do I apply the 5 Ms to the older patients in my office?
• When is it time to refer an older patient to a geriatrician?

Speaker: Tamar H. Taddei, MD, F바카라 사리트

• What are the common causes of abnormal liver enzymes observed in hospitalized patients?
• When should you consider observation and when should you initiate diagnostic work-up for abnormal liver enzymes?
• When is referral to a gastroenterologist or hepatologist indicated?

Speaker: Simona Jakab, MD, Member

• What is a high-value care approach to diagnosing the cause of new-onset acute liver failure and acute exacerbation of chronic liver disease?
• How do you best manage these two conditions in the hospital and avoid readmissions?
• When should you refer these patients for urgent or semiurgent liver transplant?

Speaker: Noble Maleque, MD, F바카라 사리트

• What is the prevalence and etiology of asymptomatic, symptomatic, and secondary hypertension in the inpatient setting?
• How do you manage the patient with asymptomatic and symptomatic hypertension, the timing of treatment, and monitoring after hospital discharge?
• What are the postdischarge adverse events associated with the treatment of asymptomatic inpatient hypertension?

Speaker: Gregory C. Kane, MD, M바카라 사리트

• How does one choose among the various options available to treat hypoxemia?
• How does one prescribe and troubleshoot the noninvasive oxygenation treatment options?
• How does one initiate mechanical ventilation and what ventilator strategies can be used to improve oxygenation?

Speaker: Aditya S. Bharadwaj, MD, MBBS, FACC, FSCAI

• What are the latest management guidelines for type 1 and type 2 myocardial infarctions (MIs)?
• What is the recommended duration of antiplatelet and other therapies administered after MI?
• What are the core quality measures in MI care that physicians should be aware of?

Speaker: Shoshana J. Herzig, MD, MPH, F바카라 사리트, SFHM

• What are the best opioid and nonopioid treatment options for patients with acute or chronic pain in the inpatient setting?
• How should you manage acute pain in patients with substance use disorder and those receiving medication-assisted treatment?
• What management and preventive strategies will help reduce treatment-related adverse events in these patients?

Speaker: Robert Cole Pueringer, MD, Member

• How do you compare and contrast the use of different approaches for the treatment of alcohol withdrawal in the detoxification unit and inpatient settings?
• What are the recent changes in the management of alcohol withdrawal syndrome?
• What outpatient treatment options should be considered at the time of discharge and other points-of-care transitions?

Speaker: John M. Kelso, MD

• How does food allergy present, and what is the high-value approach to evaluating a patient for a food allergy?
• When and how should a patient with a documented drug allergy be reexposed to that medication?
• What is the most high-value approach for diagnosing patients with an environment allergy?

Moderator: Daniel M. Goodenberger, MD, M.D. (Hon), M바카라 사리트, FRCP
Panelists: Jennifer A. DeLaney, MD, Member 鈥� William Fox, MD, M바카라 사리트 鈥� Donna Galbreath, MD

• What are the alternative models of internal medicine ambulatory practice outside of traditional/standard private or group practice?
• What are the virtues and limitations of such models?
• What are the tradeoffs in terms of access and affordability in entering into such models?

Moderator: Eliseo Guallar, MD, DrPH, Member
Panelists: Stephanie Chang, MD, Member 鈥� Christina C. Wee, MD, MPH, F바카라 사리트

• Become aware of recent studies with implications for internal medicine practice, research, and education.

Speaker: Jennifer A. Hanrahan, DO, MSc, Member

• What are the high-value approaches to selecting and prescribing antibiotics in the hospital setting?
• What are the common adverse events and drug鈥揹rug interactions associated with antibiotic use in the hospital?
• How can physicians become strong stewards and teachers of antibiotic use in the inpatient setting?

Speaker: Prashant Pendyala, MD

• What are the common electrolyte abnormalities observed in medical inpatients?
• What is the threshold to initiate work-up and treatment of such abnormalities?
• How do electrolyte disturbances aid in diagnosis and treatment?

Speaker: Anoop Agrawal, MD, F바카라 사리트, FAAP

• What are the helpful and easy-to-use apps for physicians in the inpatient setting to serve as a point-of-care learning tool?
• What apps may physicians recommend to their inpatients for better understanding and management of their disease in the hospital and following discharge?
• What are the limitations of health apps that physicians should be aware of?

Speaker: Morris Levin, MD

• What is an appropriate approach to acute severe headache?
• When should neuroimaging be used in the evaluation of headache?
• What is the evidence-based and most cost-effective approach for treatment and prevention of migraine?

Speaker: Lisa N. Boggio, MD, Member

• In which patients should autoimmune hemolytic anemias be considered, and what is the diagnostic workup?
• How are warm autoimmune hemolytic anemia and cold agglutinin disease managed?
• When should you suspect drug-induced hemolytic anemia?

Speaker: Martine Sanon, MD

• What are the common noninfectious adverse events associated with a hospital stay?
• What are the risk factors for delirium, functional decline and pressure injuries for older patients who are hospitalized?
• What strategies can help prevent the incidence of these noninfectious adverse events in hospitalized patients?

Speaker: Matthew B. Carroll, MD, M바카라 사리트, FACR

• What are monoclonal antibodies, and why are they called "biologics"?
• How do biologics target the cytokine profile of rheumatologic, dermatologic, and gastrointestinal illnesses?
• What are the benefits and risks of using biologics?

Moderator: Tracey L. Henry, MD, MPH, MS, F바카라 사리트
Panelist: Matthew J. Press, MD, MSc, F바카라 사리트

• What models of care are available, and how do I know which is best for my practice?
• How can I maximize behavioral health care for my patients when there is a shortage of psychiatric and other mental health professionals?
• What resources are available to help primary care physicians provide holistic care to their patients with mental health and/or substance use conditions?
• How can I overcome common financial, staffing, and logistical obstacles to integrating behavioral and mental health in my primary care practice?

Moderator: Susan Y. Lee, MD, F바카라 사리트
Panelists: Donna F. Heinemann, MD, F바카라 사리트 鈥� Donna Morrison, MD, F바카라 사리트 鈥� Donna Morrison, MD, F바카라 사리트 鈥� Donna Morrison, MD, F바카라 사리트

• Understand the benefits of performing the annual Medicare wellness visit.
• List the key components of the annual Medicare wellness visit.
• Identify two to three strategies to engage your team in implementing the annual Medicare wellness visit to maximize impact and efficiency.
• Identify strategies to appropriately bill and code for the annual Medicare wellness visit to ensure proper reimbursement.

Speaker: Robert M. McLean, MD, M바카라 사리트

• What should the primary care physician know about the current diagnosis and management of gout?
• What are the different types of crystalline arthritis beyond gout?
• What are some of the distinguishing characteristics that help identify calcium pyrophosphate (CPP) arthropathy from other types of calcium-based crystalline arthropathies, such as basic calcium phosphate (BCP) disease?
• What treatment options are available for CPP arthropathy?

Speaker: Juliana M. Kling, MD, MPH, M바카라 사리트

• What are the commonly used bioidentical hormones (postmenopausal hormone therapy, thyroid supplements, and adrenal supplements)?
• Is there any utility of salivary hormone testing?
• Is there a role for bioidentical hormones, and are they safe?

Moderator: Allan L. Markus, MD, MS, MBA, F바카라 사리트
Panelist: Katherine I. Harris, MD, F바카라 사리트

• Recognize the many opportunities to volunteer in your own medical and nonmedical communities.
• Discuss how having a passion outside of medicine can lead to greater engagement with your community, better relationships, and opportunities for personal growth.
• Learn from physicians who have converted passions and hobbies into community service and meaningful experiences at different stages of their work and family lives.

Speaker: James T. Whitfill, MD, MBA, F바카라 사리트, FSIIM

• How are physicians using artificial intelligence (AI) to complement medical decision making (e.g., diagnostic reasoning)?
• What are the current applications of AI in internal medicine?
• Why is physician AI vigilance important?

Speaker: Adrian BaudyIV, MD, MBA, Member

• At what GFR should a patient undergo additional evaluation for progressive kidney disease, and how should that patient be evaluated?
• What is the core of CKD management for an internal medicine physician, including issues related to hypertension, diabetes mellitus, coronary artery disease, and acidosis?
• When should a patient with CKD be referred to a nephrologist?

Moderator: Crystal S. Denlinger, MD, F바카라 사리트
Panelists: Diana L. Hanna, MD 鈥� Colin D. Weekes, MD, PhD

• What is the role of biomarkers in screening, prognosis, prediction, and treatment?
• How are biomarkers used in the diagnosis and surveillance of cancer?
• What does a biomarker-positive cancer mean?
• What, if any, is the role of circulating tumor DNA and the multicancer early detection (MCED) assays?

Speaker: Todd M. Brown, MD, MSPH

• Who should be referred for cardiac rehabilitation?
• What are the clinical benefits derived from cardiac rehab?
• What are the barriers to getting patients enrolled in cardiac rehab programs?
• How can these barriers be overcome, and/or what alternatives exist for patients?

Moderator: LaTonya B. Washington, MD, MBA, F바카라 사리트
Panelists: Armen Henderson, MD, MBA 鈥� Tanya Majumder, MD, MS

• What can be learned from the shared experiences of populations marginalized by the U.S. health care system?
• How can physicians provide contextually competent care to these populations?

Speaker: Kelly Cawcutt, MD, MS, F바카라 사리트, FIDSA, FCCM

• How do you diagnose and treat infectious endocarditis?
• How do you treat initial and recurrent Clostridioides (formerly Clostridium) difficile and prevent subsequent infections?
• How do you manage patients who are critically ill and in the ICU using appropriate antimicrobial stewardship?

Speaker: Laura Davisson, MD, F바카라 사리트, MPH

• What pharmacologic approaches have the greatest benefit for weight loss in patients with obesity?
• What are the complications of medications for obesity, and how should they be managed?
• How can busy clinicians treat obesity despite medication shortages and inconsistent insurance coverage?

Speaker: Anelyssa D'Abreu, MD

• How should primary care physicians assess for cognitive impairment?
• What clinical features should prompt evaluation beyond a diagnosis of Alzheimer dementia?
• What are effective treatment strategies for differing types of dementia?
• What is the role of new antiamyloid biologic therapies?

Speaker: Elizabeth Cerceo, MD, F바카라 사리트, FHM

• How can my ICU help lessen climate change?
• How can I help prepare my ICU for the worsening impacts of climate change?
• What is the COP26 Health Programme? Any updates from COP28?

Moderator: John B. Bundrick, MD, M바카라 사리트
Panelists: Michael W. Cullen, MD, FACC 鈥� Rodolfo Savica, MD, PhD

• Test your clinical acumen by answering challenging patient management questions faced in practice.
• Compare your critical thinking with that of your colleagues.
• Amass a rich collection of "pearls" that can be applied to patient care.

Moderator: John B. Bundrick, MD, M바카라 사리트
Panelists: Andrea Kattah, MD 鈥� Jacob J. Strand, MD, F바카라 사리트

• Test your clinical acumen by answering challenging patient management questions faced in practice.
• Compare your critical thinking with that of your colleagues.
• Amass a rich collection of "pearls" that can be applied to patient care.

Moderator: John B. Bundrick, MD, M바카라 사리트
Panelists: Hannah C. Nordhues, MD, MSCP, F바카라 사리트 鈥� Brandon Verdoorn, MD

• Test your clinical acumen by answering challenging patient management questions faced in practice.
• Compare your critical thinking with that of your colleagues.
• Amass a rich collection of "pearls" that can be applied to patient care.

Moderator: Alan Dow, MD, MSHA, F바카라 사리트
Panelists: Ruth Etzioni, PhD 鈥� Aimee Lucas, MD, F바카라 사리트, FACG 鈥� Aimee Lucas, MD, F바카라 사리트, FACG 鈥� Maryam Lustberg, MD

• Segment A: Breast
  • 1. What is the most evidence-based approach (start, frequency, and modality) for screening women at average risk for breast cancer?
  • 2. How should breast density impact the screening approach?
  • 3. How should women at higher risk be classified, and how should each classification be screened?
• Segment B: Prostate
  • 1. What is the most evidence-based approach (start, frequency, and modality) to prostate cancer screening for patients at average risk?
  • 2. What is the role of MRI in prostate cancer screening?
  • 3. How should an internal medicine physician manage an elevated PSA?
• Segment C: Pancreas
  • 1. Which patients are at higher risk for pancreatic cancer?
  • 2. What is the most evidence-based approach (start, frequency, and modality) to screening for pancreatic cancer?
  • 3. How should imaging findings guide screening and surveillance for pancreatic cancer?
  • 4. How should incidental pancreatic cystic lesions be followed, specifically intraductal papillary mucinous neoplasms (IPMN)?

Moderator: Kerry A. Esquitin, MD, F바카라 사리트, FACC, FASE, RPVI
Panelists: Anjori Bhatia Dunbar, MD 鈥� Ariela R. Orkaby, MD, MPH, Member 鈥� Karol E. Watson, MD, PhD

• Segment A: Older Adults
  • 1. What are the screening recommendations for coronary artery disease in older adults?
  • 2. What are the recommendations regarding statin use in older adults?
  • 3. What special considerations must be taken into account when managing coronary artery disease in the older adult?
• Segment B: Women
  • 1. What cardiovascular risk factors are unique to women (including adverse reproductive outcomes)?
  • 2. What gender differences exist with respect to symptoms, presentation, and management of coronary artery disease?
  • 3. How effective are primary prevention strategies in women compared with men?
• Segment C: Patients with Diabetes
  • 1. What are the screening recommendations for coronary artery disease in patients with diabetes?
  • 2. Which medications and lifestyle modifications should be instituted in patients with diabetes for primary prevention of coronary artery disease?
  • 3. What are the guidelines for revascularization in patients with diabetes found to have coronary disease?

Moderator: Crystal S. Denlinger, MD, F바카라 사리트
Panelists: Erin Bange, MD, MSCE 鈥� Theresa A. Hastert, PhD, MPP 鈥� Cardinale B. Smith, MD, PhD

• Segment A: Practical
  • 1. How should one screen for practical concerns, such as financial distress, time toxicity, and concerns about work ability in patients with cancer?
  • 2. How can practical needs affect cancer treatment and outcomes?
  • 3. What is the role of the primary care physician in supporting practical needs in patients with cancer?
• Segment B: Social
  • 1. What are the highest-priority health-related social needs?
  • 2. How do health-related social needs affect cancer treatment and outcomes?
  • 3. What are some best practices for evaluating health-related social needs?
  • 4. How can primary care physicians play a role and support their patients with cancer?
• Segment C: Emotional
  • 1. What emotional needs are most common in patients with early-stage cancer and survivors?
  • 2. What emotional needs are most common in patients with advanced cancer?
  • 3. What role can primary care physicians play in addressing and supporting these needs?

Moderator: Crystal S. Denlinger, MD, F바카라 사리트
Panelists: Narjust Florez, MD, Member 鈥� Tejas Patil, MD 鈥� Kim L. Sandler, MD

• Segment A: Advanced Lung Cancer
  • 1. What are the biomarkers that drive treatment decision making in advanced lung cancer?
  • 2. How are treatment paradigms evolving in first-line treatment?
  • 3. How has the treatment of small cell lung cancer evolved?
• Segment B: Early-Stage Lung Cancer
  • 1. What are the current local treatment approaches for early-stage lung cancer?
  • 2. What are the treatment options for neoadjuvant and adjuvant therapy in early-stage lung cancer?
  • 3. What issues arise in the care of survivors of lung cancer?
• Segment C: Lung Cancer Screening
  • 1. What is the benefit of lung cancer screening?
  • 2. What are the current lung cancer screening recommendations according to available clinical practice guidelines?
  • 3. How should patients be counseled regarding risks and benefits of lung cancer screening?

Speaker: Ali Gharavi, MD

• Which patients should be considered for genetic testing in primary care?
• When should a primary care physician order genetic testing, and when should a patient be referred to a genetics counselor?
• How should a primary care physician counsel patients who present with genetic test results done by independent companies?

Speaker: Rachel Issaka, MD, MAS

• Who is at increased risk for colon cancer?
• How do we improve colon cancer screening among underscreened populations?
• What is the role of stool and serologic testing in colon cancer screening?

Speaker: John M. Kelso, MD

• How does a physician identify, manage, and treat life-threatening allergic and hypersensitivity conditions encountered in the inpatient setting?
• How does one navigate and address the drug and antibiotic allergies reported by patients and EHRs?
• When is it appropriate to apply inpatient direct oral penicillin challenge, and what is the best approach?

Speaker: Robert L. Trowbridge, MD, M바카라 사리트

• What are the common diagnostic errors encountered in the inpatient setting?
• What are the predisposing factors and signals for diagnostic error in the inpatient setting?
• How can physicians mentor their trainees to avoid diagnostic errors?

Speaker: Matthew B. Carroll, MD, M바카라 사리트, FACR

• What are rheumatologic urgencies that patients might be admitted for?
• What are the clinical, serologic, and radiographic findings to suggest a multisystem illness that could be due to a rheumatologic cause?
• How should disease-modifying agents (DMARDs) and biologics be managed during a patient's hospitalization?

Speaker: Matthew B. Carroll, MD, M바카라 사리트, FACR

• What are some of the common types of shoulder pain conditions that an internal medicine physician might encounter in their daily practice?
• What are symptoms or clinical findings that should prompt an internal medicine physician to refer a patient to orthopedics for their shoulder pain?
• What are the pharmacologic and nonpharmacologic interventions that are available for an internal medicine physician to use when diagnosing and treating shoulder pain in their patient?

Speaker: Derek M. Smith, MD, Member

• What are symptoms and clinical examination findings that are suspicious for common variable immunodeficiency (CVID)?
• What are the serologic studies needed to help identify patients with CVID?
• What are the treatments currently available for patients who are diagnosed with CVID?

Moderator: Rachel L. Ramirez, MD, F바카라 사리트
Panelists: Mara Gordon, MD 鈥� Reed V. Tuckson, MD, F바카라 사리트

• What are the most common sources of misinformation in obesity care and how do they impact stigma, bias, and potential to advance health equity for people with obesity?
• What strategies show promise toward reducing misinformation in obesity care?
• What innovative approaches have been developed by 바카라 사리트 and chapter grantees to combat misinformation in obesity care?

Co-Moderators: Geno J. Merli, MD, M바카라 사리트, FHM, FSVM 鈥� Howard Weitz, MD, M바카라 사리트, FRCP (Lond.), FACC

• Join the Annals Consult Guys as they address a variety of clinical issues while using humor to deliver educational pearls related to the practice of internal medicine.

Speaker: Stacy Menees, MD

• What is the optimal treatment for a patient with fecal incontinence?
• How does one treat constipation in a patient with high-care needs (e.g., patients in a skilled nursing facility)?
• How does one treat diarrhea in a patient with high-care needs (e.g. patients in a skilled nursing facility)?

Speaker: Cynthia M. Boyd, MD, MPH, F바카라 사리트

• When is it appropriate to deprescribe medications?
• What are the guidelines available to deprescribe medications?
• What are some successful strategies used while discussing deprescribing with patients?

Speaker: Vikas Majithia, MD, MBBS, MPH, F바카라 사리트, FACR

• In which patients should spondyloarthropathy be considered, and what are the differences and similarities between subtypes of this heterogeneous disorder?
• How do you differentiate spondyloarthritis from other causes of inflammatory arthritis, including rheumatoid arthritis?
• How do you identify and diagnose axial spondyloarthritides, radiographic and non-radiographic?

Speaker: Stephanie Schmitz, MD, Member

• When should a physician diagnose a treatment failure in depression and anxiety disorders?
• What is the most evidence-based approach to augmenting therapy for depression and anxiety disorders?
• When should a physician suspect an alternative diagnosis to major depression or general anxiety disorder?

Speaker: Amy Bregar, MD

• What are the common diseases that present with vulvar symptoms, including lichen sclerosis and vulvar lichen planus and vulvar cancers?
• How can they best be diagnosed?
• What are the management strategies for benign conditions?
• What is the treatment and prognosis for vulvar cancer?

Speaker: Jason Karlawish, MD

• Describe the latest understanding of the pathogenesis of Alzheimer dementia including the impacts of the social determinants of health.
• Identify how insights into the pathogenesis of Alzheimer dementia may guide therapies for this condition.
• Articulate approaches that may prevent Alzheimer dementia based on the current understanding of this condition.

Speaker: Richard A. Marottoli, MD, MPH

• What are the concerns about an older driver on the road?
• Using the available guidelines, how can I evaluate an older adult's driving ability?
• How do I use a patient-centered approach to effectively counsel an older adult about driving limitations or cessation?

Speaker: Simrankaur Kaur Matta, MD

• What are the early, not-so-obvious clinical signs of rapid decompensation in patients hospitalized on the wards, and how do I identify them?
• What are the common clinical decision-supporting tools to diagnose such patients and manage them appropriately, especially when higher-level care transfer options are limited?
• What conditions can commonly present with early subclinical signs predictive of deterioration in the near future?

Moderator: Jan K. Carney, MD, MPH, M바카라 사리트
Panelists: Kari Esbensen, MD, PhD, F바카라 사리트 鈥� Laurie J. Lyckholm, MD, F바카라 사리트

• What are the implications of "slow" or "show" codes for respect for patient autonomy, the patient鈥損hysician/surrogate relationship, and physician professional judgment and integrity?
• How should physicians respond to requests that are inconsistent with established and accepted medical standards of care?
• What ethical issues should physicians consider in these situations?

Moderator: Megan Hiles, MD, MBA, F바카라 사리트
Panelists: Jitendra Barmecha, MD, MPH, M바카라 사리트, SFHM 鈥� John J. Whyte, MD, MPH, F바카라 사리트

• Discuss criteria and resources physicians can use to evaluate the quality and validity of patient-facing apps and other digital health tools, including app certification programs, published evaluations, expert reviews, and applicability to specific patient populations.
• Examine the types of apps designed for common chronic conditions in internal medicine, and distinguish apps with research evidence supporting improved outcomes from apps lacking evidence.
• Develop strategies to guide patients in selecting high-quality, evidence-based apps while avoiding apps making unsubstantiated claims or posing privacy risks.

Speaker: Rohul Amin, MD, F바카라 사리트

• What is the best approach to diagnosing attention deficit鈥揾yperactivity disorder (ADHD) in adults?
• What is a pragmatic approach to ADHD management in the time-constraint environment of a primary care physician?
• What should alert providers to medication misuse or diversion when treating patients with ADHD?

Speaker: Waqar Qureshi, MD, FRCP, FASGE, FACG

• What is appropriate evaluation and management of rectal bleeding?
• What is the most appropriate evaluation and management of constipation?
• What are common causes and treatments of perianal rash and itching?
• What is appropriate evaluation and management of perirectal pain?

Speaker: Rachel S. Rubin, MD, IF, NCMP

• What is the prevalence of female sexual dysfunction, how is it characterized, and what is the differential diagnosis?
• What nonpharmacologic therapies are available? In particular, how does sex therapy work and how can a clinician find a sex therapist?
• What pharmacologic therapies are available, and how effective are they?

Moderator: Rebecca Andrews, MS, MD, F바카라 사리트
Panelists: Lisa Bellini, MD, M바카라 사리트 鈥� Molly Moravek, MD, MPH, MSCI

• What are challenges that physicians face when considering family planning during medical training?
• What are the potential implications and impact on fertility and pregnancy complications for physicians considering the timing of pregnancy and family planning?
• Are there considerations that may be important for physicians who plan to start a family later in their careers?
• What are the local, regional, and national policy concerns regarding fertility and family planning for physicians-in-training?

Moderator: Noel N. Deep, MD, M바카라 사리트, FRCP
Panelist: Matthew DeCamp, MD, PhD, F바카라 사리트

• What key ethical challenges are raised by the increasing employment of physicians?
• How should physicians respond to institutional policies or contractual arrangements that incentivize the welfare of the institution over the interests of patients?
• How should physicians respond to expectations that they solicit charitable contributions from patients?

Speaker: Matthew B. Carroll, MD, M바카라 사리트, FACR

• What are the common causes of foot and ankle pain that an internal medicine physician should be familiar with?
• What are some of the pharmacologic and nonpharmacologic interventions that are appropriate for the variety of foot and ankle conditions that an internal medicine physician might encounter in routine clinical practice?
• When should an internal medicine physician consult an orthopedic surgeon or podiatrist to help address foot or ankle pain affecting their patient?

Moderator: Christine Laine, MD, MPH, F바카라 사리트
Panelists: Liana K. Billings, MD 鈥� Zehavi Horowitz-Kugler, MD 鈥� Adam J. Obley, MD, F바카라 사리트

• Authors of three selected articles to be published during the Internal Medicine Meeting will present a 10-minute overview of their article.

Moderator: Haidn Foster, MD, Resident/Fellow Member
Panelists: Jorge A. Ramallo, MD, MPH, F바카라 사리트, FAAP 鈥� Ames Simmons, JD

• What are the unique health needs of transgender and gender-diverse (TGD) patient populations?
• What are the current policy and legal threats and opportunities for gender-affirming care at the local, state, and federal level?
• What are some policy approaches and considerations at the local, state, and federal level that can be taken to improve TGD health?
• What steps can physicians and medical professionals take to make their medical practice inclusive and meet the needs of TGD patient populations?

Speaker: Sue S. Bornstein, MD, M바카라 사리트

• How should primary care physicians ask patients about firearms?
• What do primary care physicians need to know about firearms to counsel patients effectively to prevent firearm-related injury?
• What is the role of the general internal medicine physician in reducing the risk for workplace-related gun violence?

Speaker: Dana M. Blyth, MD, F바카라 사리트, FIDSA

• What are the common health care鈥揳ssociated infections in the inpatient setting?
• What management tools can lead to early diagnoses and reduction in morbidity, mortality, and length of stay associated with such infections?
• What high-value care strategies can prevent the occurrence of such infections?

Speaker: Joshua Chodosh, MD, MSHS, F바카라 사리트

• Is there a right time to assess for and recommend hearing aids?
• What are the most effective ways to help manage and treat hearing loss, including cochlear implants?
• What is the latest evidence connecting hearing loss and cognition?

Speaker: Astrid Pujari, MD

• Which herbal medicines are commonly used by patients?
• For which side effects and medication interactions should clinicians be alert?
• What clinical scenarios should prompt a clinician to more carefully review a patient鈥檚 history for herbal medication use?

Speaker: Jim Chimiak, MD

• How do I clear my patient with asthma or COPD to safely scuba or free dive?
• What are the risks of diving in the patient with lung disease?
• What testing should be done to see whether my patient with pulmonary disease can travel by air safely?
• What are considerations for those that may require supplemental oxygen during air travel (e.g., acute conditions that would include flying after diving, after/before hyperbaric O2 Rx)?

Moderator: Earl StewartJr., MD, F바카라 사리트
Panelists: Kevin Fiori, MD, MPH, MS, FAAP 鈥� Jamar Slocum, MD, MBA, MPH, F바카라 사리트

• List strategies to identify and mitigate bias.
• Engage a broad group of stakeholders to help prioritize improvement efforts.
• Use a population health approach to improve patient outcomes.
• Engage in efficient and effective cost-of-care conversations.

Speaker: Daniel D. Dressler, MD, MSc, F바카라 사리트, MHM

• What are the essential elements of physical examination that should be performed during daily visit on medical inpatients?
• What are the high-yield physical exam findings that inpatient physicians should be familiar with?
• How do you develop mastery in the high yield physical signs and teach these concepts to trainees?

Speaker: Joseph E. Marine, MD, Member, FACC

• What are the appropriate indications for using telemetry in the hospital setting?
• What are the risks of overusing telemetry in the inpatient settings?
• When should cardiology be consulted for benign and asymptomatic findings on a routine telemetry monitoring?
• What major telemetry findings warrant further evaluation?

Moderator: Moises Auron, MD, F바카라 사리트, FAAP, SFHM, FRCP
Panelists: Eileen Barrett, MD, MPH, M바카라 사리트, FAMWA, SFHM 鈥� Richard M. Wardrop III, MD, PhD, M바카라 사리트, FAAP, SFHM

• Define value and the limitations of selected educational approaches in the setting of medical education.
• Apply principles of evidence-based curricular design and evaluation to one's own educational efforts.
• Introduce modifications to educational activities that are of low value.

Moderator: Shari M. Erickson, MPH
Panelists: George LyonsJr., JD-MBA 鈥� Brian E. Outland, PhD

• Provide an extremely timely and in-depth presentation on hot public policy issues that are of most concern to internal medicine.
• Learn what 바카라 사리트 is doing about these issues and how members can become involved.
• Provide an opportunity for direct questioning of 바카라 사리트 Washington staff.

Moderator: Kari Esbensen, MD, PhD, F바카라 사리트
Panelist: Kyle E. Karches, MD, PhD, F바카라 사리트

• What are the emerging medical ethics and professionalism issues for internal medicine physicians today?
• How do ethical issues affect patient care?
• What should clinicians consider and how should interests be balanced when ethical challenges arise?

Moderator: Ross W. Hilliard, MD, F바카라 사리트
Panelists: Sharath Kharidi, MD, F바카라 사리트, FAMIA 鈥� Gary Weissman, MD

• Be exposed to current hot topics in medical informatics.
• Participants will interact with faculty to learn how these new technologies and concepts may affect their practices.
• Become familiar with 바카라 사리트鈥檚 digital health resources.
• Hot Topic #1: Cybersecurity
• Hot Topic #2: Equity Considerations in Health Care AI

Moderator: Ellen Gelles, MD, F바카라 사리트
Panelists: Stephen P. Ma, MD 鈥� Deepti Pandita, MD, F바카라 사리트, FAMIA

• Learn how augmented intelligence (AI) and machine learning (ML) technologies are used in health care to tackle administrative tasks and other burdensome aspects of clinical care.
• Identify the risks and benefits of these technologies and what questions to ask when you or your practice are considering integrating them.

Speaker: Eileen Barrett, MD, MPH, M바카라 사리트, FAMWA, SFHM
Speaker: Ian Motie, MD, Resident/Fellow Member

• Identify strategies to be an engaging speaker, and learn how to tailor talks by audience.
• Expand and hone your public speaking skillset, especially as a physician.
• Learn common pitfalls in public speaking.

Moderator: Ankita Sagar, MD, MPH, F바카라 사리트
Panelist: Elizabeth Cerceo, MD, F바카라 사리트, FHM

• Describe the internal medicine physician shortage and features of thriving systems where physicians, their teams, and patients' needs are met long term.
• List strategies and interventions proven to help retain internal medicine physicians in the clinical workforce.
• Identify strategies to promote the fulfillment of practicing internal medicine physicians and their clinical teams.

Moderator: William D. Surkis, MD, F바카라 사리트
Panelist: Michael Ganio, PharmD, MS, FASHP

• Describe the impact of drug shortages on patient care.
• List strategies the U.S. Food and Drug Administration and other key stakeholders are taking to mitigate drug shortages.
• Identify two to three examples of how practicing physicians can limit the negative impact of drug shortages on their patients.

Co-Moderators: Carrie A. Horwitch, MD, MPH, M바카라 사리트 鈥� Olga Karasik, MD, F바카라 사리트

• How does humor support health?
• How should clinicians use humor to enhance care?
• How can humor support clinician well-being?

Speaker: Jan Basile, MD, FAHA

• What factors should determine the appropriate blood pressure goal for different patients?
• When should patients be diagnosed with resistant hypertension, and how should they be managed?
• What is the role of home or ambulatory blood pressure for diagnosis and monitoring?

Speaker: Joan Briller, MD

• What are the optimal blood pressure targets during pregnancy?
• What is the association between hypertensive disorders of pregnancy and future cardiovascular disease?
• What geographic, social, and environmental factors are associated with the development of hypertension in pregnancy?

Speaker: Kerry Reynolds, MD

• In which patients should immunotherapy-related toxicities be considered, and how should these patients be evaluated?
• What is the role of the multidisciplinary team in management of immune-mediated toxicities?
• What are the currently available clinical practice guidelines for identifying and managing toxicities related to immunotherapy?

Speaker: Athena Philis-Tsimikas, MD, Member

• Choosing the right glucose target in older adults: when to intensify and deintensify treatment?
• How should physicians choose the initial and ongoing therapy for different patient populations?
• How should physicians choose therapy for cardiovascular and renal protection in type 2 diabetes?

Co-Moderators: Ricardo G贸mez Huelgas, MD, PhD, F바카라 사리트, F바카라 사리트 (Hon) 鈥� Isaac Opole, MD, PhD, M바카라 사리트
Panelists: Luis Campos, MD, MSc, FEFIM, F바카라 사리트 (Hon) 鈥� Elizabeth Cerceo, MD, F바카라 사리트, FHM

• Understand and identify the direct and indirect health risks posed by climate change. This includes recognizing the increased incidence of heat-related illnesses, exacerbation of chronic conditions (e.g., respiratory diseases and cardiovascular issues), infectious diseases, and mental health challenges resulting from extreme weather events and environmental changes.
• Promote strategies to prevent and mitigate the health effects of climate change.
• Advocate for policies that reduce carbon emissions, promote lifestyle changes to decrease individual carbon footprints, emphasize vaccination to alleviate the spread of climate-sensitive diseases, and educate patients on managing chronic conditions effectively.
• Address climate-related health impacts comprehensively. Work with public health officials, environmental scientists, policymakers, and community leaders to develop and implement initiatives aimed at both mitigating climate change and improving health outc
• Develop patient education to empower individuals in recognizing and responding to climate-related health risks.

Speaker: Thomas K.M. Cudjoe, MD, MPH, MA

• What is the evidence linking social connection and health outcomes?
• How should health care providers assess patients for loneliness and social isolation?
• What interventions have been shown to decrease loneliness and social isolation, and enhance subsequent health outcomes?

Speaker: Aneesh V. Tolat, MD, FACC, FHRS

• How do I manage patients presenting with their first episode of atrial fibrillation and those with a history of atrial fibrillation presenting with rapid ventricular rates?
• What are the management options for patients with refractory atrial fibrillation?
• What are the special considerations for adjusting anticoagulants in hospitalized patients?

Speaker: Rodolfo J. Galindo, MD, FACE

• When and how does the physician screen patients for inpatient hyperglycemia?
• How does one choose the right inpatient treatment (insulin vs. oral agents) for the management of diabetes and hyperglycemia?
• How does the physician choose the right diabetes treatment after discharge?

Speaker: Avital Y. O'Glasser, MD, F바카라 사리트, SFHM, DFPM

• What are the most recent perioperative guidelines, and how does one apply them in clinical practice?
• What is the role of the medical consultant in the perioperative period?
• How are troponin elevation and myocardial ischemia in the postoperative period addressed?

Speaker: Michael J. Sanley, MD

• What are the common conditions associated with wheezing in inpatients?
• What are the various causes of wheezing at the bedside, from upper airway to lower airway and from airway inflammation to airway fluid?
• Is there a role for spirometry and additional pulmonary function testing in the plan of care for such hospitalized patients, and what is the timing of such testing if indicated?

Moderator: Joel C. Diamant, MD, M바카라 사리트
Panelists: Michel A. Cramer Bornemann, MD, DABSM, DABMS-SM, FAASM 鈥� Derek Loewy, PhD

• What constitutes the essential history and diagnostic evaluation in a patient with insomnia?
• What are the effective lifestyle, nonpharmacologic, and medication treatments for insomnia?
• What parasomnias are common in primary care?
• How should a patient be evaluated and treated for parasomnias?

Moderator: Alan Dow, MD, MSHA, F바카라 사리트
Panelists: Stephen Biederman, MD, F바카라 사리트 鈥� Christian Cable, MD, MHPE, M바카라 사리트 鈥� Ann R. Garment, MD, F바카라 사리트

• Hear three outstanding clinician鈥揺ducators share what they think are Internal Medicine Meeting 2025鈥檚 most important take-home messages. Then, join the excitement of the final round of Doctor鈥檚 Dilemma庐. The 鈥淔inal Five鈥� teams of residents who survive the Thursday and Friday competitions will face off in the championship round of this Jeopardy-style test of knowledge. The winner takes home the Osler Cup鈥�바카라 사리트鈥檚 coveted trophy.

Speaker: Fawad A. Khan, MD

• What are the essential historical features of a seizure?
• What is the appropriate diagnostic evaluation of an isolated seizure in an adult?
• What is the most evidence-based approach for initiating antiepileptic treatment?
• What is the management of seizure clusters in the hospital?

Presenter: Manish Singla, MD, F바카라 사리트

• Discuss work-ups other than endoscopy for irritable bowel syndrome.
• What over-the-counter treatments are available for constipation and diarrhea?
• What pharmaceutical therapies are available for constipation and diarrhea?

Speaker: Brett W. Sadowski, MD, F바카라 사리트

• How should physicians screen for steatotic liver disease in the ambulatory primary care clinic?
• What is the role of liver elastography testing and serologic testing for fibrosis?
• What are the treatment options for those with steatotic liver disease?

Speaker: Shudhanshu Alishetti, MD

• What conservative strategies can be employed to keep patients with heart failure out of the hospital?
• What devices and remote monitoring techniques are available for managing patients outside of the hospital?
• What barriers exist to keeping patients with heart failure out of the hospital, and how can they be addressed?

Speaker: Richard E. Greene, MD, MHPE, F바카라 사리트

• How should the sexual history evolve from what physicians were taught in medical school?
• What are the essential questions of the sexual history in 2025?
• How will having a better sexual history impact the care of my patients?

Moderator: Matthew Sakumoto, MD, F바카라 사리트
Panelists: David C. Kaelber, MD, PhD, MPH, F바카라 사리트 鈥� Deepti Pandita, MD, F바카라 사리트, FAMIA

• Discuss ways in which digital health tools can be used to advance health equity.
• Learn strategies for implementing these tools in practice and discussing the use of these tools with patients.
• Learn from these tools to drive best practices to bridge the equity gap given that digital equity is not equal to health equity.
• Understand how these tools assist clinicians in closing these gaps and mitigating disparities in care.

Speaker: Scott C. Woller, MD, F바카라 사리트, FCCP

• Periprocedural anticoagulation management: Balancing thrombosis and bleeding risk.
• Direct oral anticoagulant use in special populations, such as extremes of body weight, kidney, and hepatic insufficiency. Is there a role for dose-adjustment?
• When should I elect a vitamin K antagonist over a direct oral anticoagulant?

Speaker: Mark C. Bicket, MD, PhD, FASA

• What are effective, opioid-sparing approaches for management of chronic pain?
• When should opioids be used, and how should the best one be selected and dosed?
• How does one most safely taper and switch opioids used for pain control?
• What is the best approach to managing a patient with chronic pain who has developed OUD?

Speaker: Kristen Manley, MD, Member

• What are the common oncologic emergencies encountered in the hospital?
• What are the high-value signs and symptoms that help to identify common oncologic emergencies?
• How are common oncologic emergencies best managed?

Speaker: Farid Jadbabaie, MD

• How should physicians effectively manage patients hospitalized with heart failure with preserved ejection fraction (HFpEF)?
• Which therapies should be initiated in patients with HFpEF before discharge?
• When should a patient diagnosed with HFpEF be referred to advanced heart failure services?

Speaker: Christian J. Woods, MD, F바카라 사리트, FCCP, FIDSA

• What are the current diagnostic approaches to improve appropriate antibiotic usage for respiratory infections?
• What are the updates for managing community- and hospital-acquired pneumonia?
• What are the latest recommendations for managing influenza?

Speaker: Michael E. Goldberg, DO

• What imaging should a physician order if they are concerned about gallstones?
• How does an internal medicine physician diagnose and manage pancreatic insufficiency?
• How does one monitor pancreatic cysts?

Speaker: Jake Bartholomy, PT, DPT

• What is the best approach to screen for and diagnose pelvic floor dysfunction (PFD) after childbirth? Who is at risk for PFD?
• What are the therapies to help with incontinence and constipation in the setting of PFD?
• What is the best approach to screening for pelvic floor dysfunction in patients assigned male at birth?

Speaker: Michael S. Okun, MD

• What are some early presentations of movement disorders that may be missed by busy clinicians?
• What is the high-value evaluation of a patient presenting with tremor and/or gait instability?
• Which movement disorders can be safely managed in a primary care setting and how?

Speaker: Srilakshmi Mitta, MD

• What are the common peripartum emergencies that inpatient physicians may get called to help with?
• What are the strategies to expeditiously manage such emergencies?
• What are the best practices in co-managing these patients with the obstetric team?

Speaker: Douglas S. Paauw, MD, M바카라 사리트

• Why do medical myths persist for decades?
• What are some examples of deeply rooted medical myths?
• What are some common myths patients believe in that are not generally believed by physicians?

Speaker: Anthony J. Olszanski, MD, RPh

• In which patients should a skin lesion be considered worrisome, and how do melanoma skin lesions present in various skin tones?
• How is metastatic melanoma treated, including oligometastatic disease?
• What are some long-term survivorship concerns for people with a history of melanoma?

Moderator: Amir Qaseem, MD, PhD, MHA, MRCP (Lon), F바카라 사리트
Panelists: Robert H. HopkinsJr., MD, M바카라 사리트, FAAP 鈥� Vidya Sundareshan, MD, MPH, F바카라 사리트, FIDSA

• What are the latest updates to the 2025 Advisory Committee on Immunization Practices (ACIP) adult immunization schedule?
• What is the evidence informing the updated recommendations?
• How can I implement these recommendations into my practice?

Moderator: Amir Qaseem, MD, PhD, MHA, MRCP (Lon), F바카라 사리트
Panelists: J. Thomas CrossJr., MD, MPH, F바카라 사리트, FAAP 鈥� Devan Kansagara, MD, MCR, F바카라 사리트

• What are the latest 바카라 사리트 clinical guidelines and best practice advice relating to treatments for depression and the use of cannabis for management of noncancer chronic pain?
• What are the current standards of evidence-based care?
• How can I implement these clinical guidelines and best practice advice into my practice?

Moderator: Rachel P. Brook, MD, F바카라 사리트
Panelists: William F. Lewis, MD 鈥� Ami Thakor Philipp, MD 鈥� Nirav R. Shah, MD, MPH, M바카라 사리트

• Dermatology:
  • 1. What is the management and work-up of nonspecific hair loss? What about minoxidil in young patients?
  • 2. Dermatology best practices: Should everyone be getting an annual total body skin examination? What are the best and worst use cases of liquid nitrogen for busy primary care physicians?
• Allergy and Immunology:
  • 1. At what point should we be considering biologic agents for our patients with chronic rhinosinusitis or asthma? Are we under- or overutilizing these medications?
  • 2. For our primary care adult patients, who is a candidate for omalizumab injections for food allergies?
  • 3. When should the generalist consider intranasal epinephrine versus injectable?
• Artificial Intelligence:
  • 1. What are some high-quality artificial intelligence (AI) diagnostic reasoning tools, and how do you evaluate these AI products to assess for diagnostic accuracy? What are some common pitfalls to be aware of when using these tools?
  • 2. What are three ways you could integrate AI into your daily practice as a generalist to improve patient outcomes?

Moderator: Alexandra M. Goodwin, MD, Member
Panelists: Victoria E. Burke, MD, F바카라 사리트 鈥� Jennifer Haglund, MD 鈥� Fred A. Lopez, MD, M바카라 사리트 鈥� Bobby B. Najari, MD, MSc

• Infectious Diseases:
  • 1. What is the current evidence for outpatient treatment of COVID-19 in vaccinated versus unvaccinated patients?
  • 2. Pneumococcal soup: For patients vaccinated with PCV23 and either Prevnar 13 or Prevnar 20, is there a need for PCV21? What are the guidelines around pneumococcal vaccination?
  • 3. What is the evidence supporting doxy PEP (doxycycline postexposure prophylaxis), and what are the best practices for counseling patients on its use?
• Men's Health:
  • 1. How can primary care physicians manage low testosterone? Who should be receiving testosterone replacement, and what are the risks of hormone replacement therapy?
  • 2. How can primary care physicians manage lower urinary tract symptoms in men? What are the updates in evidence-based treatments for benign prostatic hyperplasia (BPH) and distinguishing and managing overactive bladder and BPH in men?
• Hepatology:
  • 1. What are the emerging evidence-based medications for treatment of MAFLD, including, but not limited to, GLP-1 receptor agonists ? When do you initiate medication treatment versus lifestyle modifications?
  • 2. What should we know about the initiation of treatment of hepatitis C in hospitalized patients? For what patient populations is it indicated and most beneficial?

Moderator: James O'Keefe, MD, F바카라 사리트
Panelists: Walter S. Dunn, MD, PhD 鈥� Keith C. Ferdinand, MD, FACC, FAHA, FNLA, FASPC 鈥� Jose Ricardo Lopez Castellanos, MD

• Psychiatry:
  • 1. What are the latest updates in treating treatment-resistant depression, including the role and indications for ketamine?
  • 2. What are the current indications and emerging data for the use of hallucinogens like psilocybin? For which conditions should we consider these treatments?
• Neurology:
  • 1. For patients with autonomic dysfunction, what is the evidence-based approach to initiation and selection of blood pressure鈥揳ugmenting medications? When should we consider pyridostigmine, and what should internal medicine physicians know about its risk factors and management?
  • 2. For common neurodegenerative diseases encountered in primary care, how is the role of biomarker testing evolving? What are some high-yield diagnostic tests, such as blood or CSF testing, skin biopsy, and imaging techniques, and their clinical utility in making a diagnosis?
• Cardiology:
  • 1. What is the approach to integrating Lp(a) into your cardiac risk stratification? Who benefits from testing, and how do you factor the result into your management strategy?
  • 2. In patients with systolic heart failure with preserved or mildly reduced ejection fraction, when should we initiate treatment with finerenone? Should we start SGLT-2 medications in hospitalized patients? What specific patient characteristics should be considered with regard to risks and benefits?

Speaker: Deborah B. Adey, MD, F바카라 사리트

• What adverse effects and complications of kidney transplant medications should I watch for?
• What potential interactions with transplant medications should I be aware of?
• What cancer screening is indicated for patients living with a kidney transplant?
• What special considerations should I be alert to for patients admitted to the hospital who are kidney transplant recipients?

Moderator: Stewart Babbott, MD, M바카라 사리트
Panelists: Tiffany I. Leung, MD, MPH, F바카라 사리트, FAMIA, FEFIM 鈥� Candace Sprott, MD, MBA, F바카라 사리트, FAAP

• Describe personal and professional factors that influence the timing and direction of career transitions.
• Identify common challenges experienced during times of career transition.
• Explore strategies to plan for successful career transitions.
• Learn ways to prioritize well-being during times of change or uncertainty.
• Identify 바카라 사리트 resources that support members during times of transition and career change.

Speaker: Chancellor Donald, MD

• What approaches have been recently implemented to enhance the treatment of acute pain crisis in patients with sickle cell disease?
• What medications have been shown to decrease the rate of complications in patients with sickle cell disease?
• How has gene editing allowed sickle cell disease to be cured?

Speaker: Gerald W. Smetana, MD, M바카라 사리트

• Which newly approved medications are likely to be prescribed by internal medicine physicians?
• What side effects of newly approved medications should internal medicine physicians be aware of?
• How do newly approved medications compare to existing medications in terms of efficacy and side effects?

Moderator: Amir Qaseem, MD, PhD, MHA, MRCP (Lon), F바카라 사리트
Panelists: Carolyn J. Crandall, MD, MS, M바카라 사리트 鈥� Jeffrey A. Tice, MD, Member

• What are the latest 바카라 사리트 clinical guidelines for prevention and treatment of acute migraine?
• What are the current standards of evidence-based care?
• How can I implement these guidelines into my practice?

Speaker: Chris Crenner, MD, PhD, F바카라 사리트

• Explore the concept of timelessness as experienced within clinical practice.
• Examine historical developments influencing experience of time in routine practice.
• Analyze how these aspects of practice play out within a couple of clinical scenarios.

Speaker: Lawrence M. Phillips, MD, M바카라 사리트, FACC

• Which patients should be evaluated with noninvasive imaging techniques for risk stratification of atherosclerotic coronary artery disease (CAD)?
• How does a physician decide which imaging modality to use with respect to an anatomic (CT) versus a functional (stress) assessment for CAD?
• What factors influence how often noninvasive imaging should be repeated?
• How are the results of these imaging studies used to guide management of patients?

Speaker: Krysta Wolfe, MD

• What is the role of noninvasive respiratory support (high-flow nasal oxygen and noninvasive ventilation) in the management of acute-on-chronic hypoxemic respiratory failure and acute respiratory distress syndrome?
• Can we use these strategies for other more chronic respiratory diseases?
• Is there evidence that noninvasive ventilation decreases or delays the need for invasive mechanical ventilation and mortality among patients with acute or chronic respiratory failure?

Speaker: Steven L. Cohn, MD, M바카라 사리트, SFHM, FRCP

• What is the most reliable way to conduct preoperative cardiac risk assessment and management to reduce risk for surgery?
• How should medications be managed perioperatively?

Lecturer: Reed V. Tuckson, MD, F바카라 사리트

• Keynote address: Professionalism In A Time Of Crisis

Speaker: Joyce E. Wipf, MD, M바카라 사리트

• How should clinicians evaluate the red eye to ensure a serious condition is not missed?
• When should a change in vision prompt an immediate ophthalmologic evaluation?
• Which subacute or chronic eye diseases are underdiagnosed by primary care?
• What tools are now readily available for internal medicine physicians to assess for asymptomatic eye disease?

Speaker: Kara Aplin, MD, F바카라 사리트

• What is the best approach to treating opioid use disorder (OUD) in the inpatient setting?
• What inpatient pharmacologic interventions can be initiated for the treatment of OUD?
• What are the high-value care approaches in care transitions on discharge and to avoid readmissions?

Speaker: Rachael Lee, MD, MSPH, Member

• How has the dogma changed around treating certain infections with oral versus intravenous therapy?
• What are the risks of prolonged oral and IV therapy?
• What is the optimal duration of treatment for common infections?

Speaker: Jeannine Z. Engel, MD, M바카라 사리트

• Learn how to use the new evaluation and management (EandM) codes, as well as other new codes, and how they affect the bottom line.
• Learn the basics of coding and documenting office visits, as well as preventive services, chronic care management, and telemedicine.

Speaker: David Spragg, MD

• How does one decide between rate versus rhythm control of atrial fibrillation in the outpatient setting?
• What patient characteristics, including comorbidities, influence management strategy?
• What pharmacologic and device therapies are used for stroke prevention, and when should they be considered?

Speaker: Sonia Malhotra, MD, MS, Member, FAAP, FAAHPM

• When is it appropriate to consider goal-concordant palliative care in the inpatient setting for nonmalignant, progressive, and chronic conditions?
• What are the best practices in conducting successful family meetings pertaining to palliative care?
• What is the approach to managing non鈥損ain-related symptoms of patients receiving palliative care?
• How do internal medicine physicians provide palliative care in the absence of available palliative care consult service in the inpatient setting?

Speaker: Foluso A. Fakorede, MD

• Which patients should be screened for peripheral vascular disease?
• How should patients with PAD be managed with respect to their cardiovascular risk?
• What conservative treatment options are available, and when should they be instituted?
• When should invasive management strategies be considered?

Speaker: Melissa McNeil, MD, MPH, M바카라 사리트

• What are the clinical manifestations of polycystic ovarian syndrome (PCOS) across the lifespan?
• What is the current understanding of the pathophysiology of PCOS, and what are the diagnostic criteria for PCOS including laboratory testing?
• What are the current management strategies for PCOS with particular emphasis on long-term cardiovascular disease?

Speaker: Susan Thompson Hingle, MD, M바카라 사리트, FRCP

• Describe features of a collaborative learning environment, including defining the hidden curriculum and mitigating its detrimental effects.
• Describe psychological safety and the importance of promoting a diverse and inclusive environment in medicine.
• Recognize concerning signs or symptoms in oneself or peers, including mental health crises or impairment, and practice compassionate responses.

Speaker: Samuel Dagogo-Jack, MD, DSc, F바카라 사리트, FRCP

• What are the diagnostic criteria and screening recommendations for prediabetes?
• Which long-term complications of diabetes occur in people with prediabetes?
• What is the recommended initial and subsequent management of prediabetes?

Speaker: Scott C. Litin, MD, M바카라 사리트

• Organize a teaching presentation with special emphasis on an effective opening and a strong closing.
• Demonstrate helpful skills for presentation techniques.
• Create and deliver your next presentation more effectively than you have in the past.
• Constructively critique presentations of others, providing helpful suggestions.

Speaker: Renata Arrington Sanders, MD, MPH, ScM

• What are the specific health care needs of LGBTQ adolescents and adults?
• What are the structural disparities that affect LGBTQ adolescents and adults, such as access to primary care, mental health care services, HIV or other specialty care, and gender-affirming care?
• How can physicians mitigate structural disparities and provide culturally competent care? What actions can physicians take to address the psychosocial and psychological care of transgender and gender-nonconforming patients?
• What are the hormone therapies for transgender adolescents and adults?

Speaker: Fred R. Buckhold III, MD, F바카라 사리트

• What are the important hospital quality metrics relevant to the hospitalist?
• What are practical tips for an early career hospitalist to incorporate quality improvement (QI) in their daily workflow?
• How does one grow a QI-minded hospital medicine group?

Speaker: Brian Morrissey, MD

• What is the epidemiology and unmet needs in patients with bronchiectasis?
• What is the evidence of long-term inhaled or oral antibiotics in clinical practice for patients with bronchiectasis?
• What are the evidence-based interventions for mucous clearance, including airway clearance/physiotherapy and mucous-targeting treatments?
• What are the future proposed targets of therapy for patients with bronchiectasis?

Moderator: Amanda C. Raff, MD, F바카라 사리트
Panelists: Deep Sharma, MD 鈥� Alexander Small, MD 鈥� Alexander Small, MD

• For a patient with kidney stones, what lab tests should be ordered and why?
• How can I help my patients reduce the risk for kidney stone recurrence?
• When should a patient with kidney stones be referred to a urologist, and what exactly will they do?

Speaker: Ellie Grossman, MD, MPH

• For what conditions are there firm data regarding the benefit of cannabis therapeutically, and for which conditions with touted benefit is supporting evidence lacking?
• What are both short- and long-term risks associated with cannabis use both therapeutically and recreationally?
• How do formulations of cannabis-based products differ in terms of efficacy and side effects, and how should providers counsel patients about these formulations?

Speaker: Sara L. Robinson, MC USN, F바카라 사리트

• What are the screening and diagnostic recommendations for sexually transmitted infections?
• What are the current recommendations for treatment and prevention of common and uncommon sexually transmitted infections?
• What is the latest on preexposure prophylaxis to prevent HIV?

Speaker: Marjorie Golden, MD, F바카라 사리트

• What are the common skin and soft tissue infections leading to hospital admission or that evolve during a hospital stay?
• How does one accurately diagnose cellulitis, and what are its mimics?
• When should internal medicine physicians seek specialist consultation from infectious diseases, surgery, or others?

Speaker: Carolyn M. D'Ambrosio, MS, MD

• Are there any new treatment modalities for insomnia?
• I suspect my patient has a sleep disorder, but they do not want to sleep in a lab. Any other options?
• My patient with severe obstructive sleep apnea (OSA) cannot tolerate CPAP. What can I offer?
• Are there any new technology devices or artificial intelligence for sleep health?

Speaker: Ronald Wyatt, MD, MHA

• What metrics are used in health equity indices for health care organizations?
• How do these measures relate to clinical practices?
• In the interest of maintaining access for patients on Medicare, how should regulatory standards differ for private practices?

Speaker: Lauren A. Weber, MD, Member, FACC

• What is the recommended approach to ASCVD risk stratification?
• Which pharmacologic agents are available for lipid control beyond statins, and what is the evidence behind them?
• What is considered adequate lipid lowering in patients with and without known coronary artery disease?

Moderator: Brian E. Outland, PhD
Panelists: Sean Cavanaugh 鈥� Joshua Liao, MD, MSc, F바카라 사리트

• Understand Medicare's Quality Payment Program, including advanced alternative payment models (APMs) and MIPS Value Pathways (MVPs).
• Learn what resources are available from 바카라 사리트 and others to help your practice succeed in the value-based payment program.
• Understand how to choose the best quality measures that both are meaningful and will be successful, including which measures 바카라 사리트 recommends.
• Appreciate how payers and ACOs are using value-based payment and how to improve your scores.

Moderator: Khalid Azzam, MBBS, CPE, MS-HQSMi, F바카라 사리트
Panelists: George M. Abraham, MD, MPH, M바카라 사리트, FIDSA, FRCP (Lon.), FEFIM 鈥� Mukta Panda, MD, M바카라 사리트, F-RCP London

• Understand the unique challenges faced by International Medical Graduate (IMG) faculty and colleagues.
• Discuss opportunities and strategies for creating a sense of belonging and community.
• Share strategies for academic and clinical integration and advancement while building a supportive environment.

Moderator: Josh Serchen, MPP
Panelists: Jennifer L. Kraschnewski, MD, MPH, F바카라 사리트 鈥� Kristin M. Mitchell, MD, F바카라 사리트

• What are the health and health care challenges faced by rural populations?
• What are innovative ways practices and health institutions have overcome barriers to providing care in rural communities?
• What are some public policy approaches and considerations at the local, state, and federal level that can be taken to improve rural health?

Speaker: Linda Overholser, MD, MPH, Member

• When does care shift from oncologists back to primary care after cancer treatment?
• What health conditions should internal medicine physicians be more alert for in cancer survivors?
• What tools can support internal medicine physicians to improve management of cancer survivors?

Speaker: Win K. Shen, MD

• What are the common causes of syncope requiring hospital admission?
• How should syncope be evaluated in the inpatient setting?
• When should you advance the care beyond a short stay for syncope?
• What is the best evaluation and management of patients with recurrent orthostatic hypotension?

Speaker: Rafael H. Llinas, MD

• What are the current guidelines in the management of stroke and TIA?
• Which patients with TIA can be safely monitored as outpatients after an ED visit?
• What are the high-cost emerging therapies in the management of stroke and TIA, and for whom are they indicated?

Speaker: Matthew Ettleson, MD

• When and how should physicians screen patients for thyroid disorders?
• When and how should a patient with subclinical hypo- and hyperthyroidism be treated?
• How does the physician counsel patients on the benefits and risks of treating subclinical thyroid disorders?

Moderator: Susan Y. Lee, MD, F바카라 사리트
Panelists: Adebisi Alli, DO, MS, F바카라 사리트, DipABLM, LEAN Six Sigma Black Belt 鈥� Diane L. Klein-Ritter, MD, F바카라 사리트

• Describe effective strategies to engage patients in vaccine conversations.
• Identify two to three practical strategies you can implement to increase immunization rates in your practice.
• Establish roles and responsibilities for members of the care team to implement a vaccine program in your practice.

Co-Moderators: Alexander D. Schafir, MD, F바카라 사리트 鈥� David R. Scrase, MD, MHSA, M바카라 사리트

• How does my clinical decision making compare with that of other internal medicine physicians?
• Can internal medicine really be this much fun, and am I allowed to laugh out loud through a whole presentation?
• Will I achieve instant fame and fortune by correctly diagnosing a case before it is presented on screen?

Moderator: Ricardo Correa, MD, EdD, F바카라 사리트
Panelists: Petal L. Elder, MD, Member 鈥� Alejandro Moreno, MBBS, MPH, JD, M바카라 사리트

• Identify common challenges encountered by early career IMG physicians practicing in the United States.
• Learn strategies to prepare for and respond to these challenges.
• Understand where to access resources valuable to early career IMG physicians.
• Cultivate a sense of community through networking, professional groups, and social media.
• Identify 바카라 사리트 resources and opportunities for IMG physicians.

Speaker: Adam Rodman, MD, MPH, F바카라 사리트

• Understand the links between diagnosis (the assignment of a disease state) and nosology (classification systems for diseases).
• Define the two metacognitive processes that surround data collection in clinical reasoning.
• Utilize cognitive psychological principles as they pertain to diagnosis.
• Draw from historical trends to better understand the potential cognitive uses of artificial intelligence in clinical medicine.

Presenter: James M. Quinn, MD, M바카라 사리트

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Joel C. Diamant, MD, M바카라 사리트

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Clyde W. Yancy, MD, MSc, M바카라 사리트, MACC, FAHA, FHFSA

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Irl B. Hirsch, MD, M바카라 사리트

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: John G. McCarthy, MD, Member

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Thomas E. Finucane, MD, M바카라 사리트
Co-Presenter: Stephanie Nothelle, MD

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: I. Romina Sosa, MD, PhD, Member

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Brian Markoff, MD, F바카라 사리트, SFHM

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Erica N. Johnson, MD, F바카라 사리트, FIDSA

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Belinda Jim, MD

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Marc Shapiro, MD, Member

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Stephanie Christenson, MD, MAS

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Robert M. McLean, MD, M바카라 사리트

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Stephanie Faubion, MD, MBA, F바카라 사리트, MSCP

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Speaker: Stephanie Christenson, MD, MAS

• What are the various intravenous (IV) fluid formulations and their indications that physicians should know?
• How does the physician assess volume status of the patient, and what should be considered when prescribing the type, dose, and duration of IV fluids?
• What are the adverse events associated with various IV fluid formulations that physicians should be aware of?
• What conditions can mimic fluid overload?

Speaker: Jeffrey M. Levine, MD, AGSF

• How should wounds be described and documented in the medical record?
• What are the common causes of wounds, and how should these causes be investigated?
• What are the best initial and second-line treatments for poorly healing wounds?

Moderator: Gustavo R. Heudebert, MD, M바카라 사리트
Panelists: Jennifer A. Meddings, MD, MSc, F바카라 사리트, FAAP 鈥� Daniel P. Morin, MD, MPH

• Recognize the role of case reports in science.
• Describe the components of a well-written case report.
• Recognize the role of case reports in education.
• Describe the pitfalls on writing a case report.